Open Label Study of Sipuleucel-T in Metastatic Prostate Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert Israel, MD
Valeant Pharmaceuticals North America LLC
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Georgetown University Medical Center
Washington D.C., District of Columbia, United States
- the University of Chicago Medical Center
Chicago, Illinois, United States
- Oncology Specialists, S.C.
Park Ridge, Illinois, United States
- Indiana University Department of Urology
Indianapolis, Indiana, United States
- Maine Center for Cancer Medicine
Scarborough, Maine, United States
- Hematology Oncology Consultants
Greenbelt, Maryland, United States
- Myron I. Murdock Md Llc
Greenbelt, Maryland, United States
- John Theurer Cancer Center at Hackensack
Hackensack, New Jersey, United States
- Columbia University Medical Center
New York, New York, United States
- Mount Sinai School of Medicine Department of Urology
New York, New York, United States
- Nyu Cancer Institute
New York, New York, United States
- Gu Oncology Research Program
Durham, North Carolina, United States
- Oncology Hematology Care, Inc.
Cincinnati, Ohio, United States
- Sarah Cannon Research Institute
Nashville, Tennessee, United States
- Texas Oncology, Pa - Sammons Cancer Center
Dallas, Texas, United States
- Urology of Virginia, Pllc
Virginia Beach, Virginia, United States
- Virginia Mason Medical Center Urology and Renal Transplantation
Seattle, Washington, United States
- Aurora Advanced Healthcare, Inc
Wauwatosa, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2009
- Primary completion
- 31 Dec 2014
- Completion
- 30 Jun 2015
- Last update posted
- 23 May 2017
- Registered enrollment
- 104
- Registry id
- NCT00901342
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.